Name | Anselamimab |
---|
Description | Anselamimab (CAEL-101) a humanized IgG1-κ anti-Amyloid fibrils antibody targeting to serum amyloid A1 (SAA1)[1][2]. |
---|---|
Related Catalog | |
Target |
Serum amyloid A1 (SAA1) |
References |
[1]. Palladini G, et al. How I treat AL amyloidosis. Blood. 2022 May 12;139(19):2918-2930. |
No Any Chemical & Physical Properties |